Four patients presented with a history of “blood” or a “dark spot” in the eye captured on cell phone photos. These episodes prompted presentation to an ophthalmologist where they all had normal slit lamp exams without a hyphema at initial evaluation. With evidence of a spontaneous hyphema seen on photos, further testing was performed including iris fluorescein angiography which revealed hyperfluorescent iris margin vascular tufts, confirming the diagnosis of iris microhemangiomatosis in each patient. All cases were managed conservatively, and only 1 needed topical antihypertensives. Without these patient-initiated photos, the diagnosis of iris microhemangiomatosis would likely remain elusive as slit lamp exam was normal at the time of initial examination in all 4 cases. Ophthalmologists should be aware of this rare diagnosis in the event a patient comes with a cell phone selfie documenting a spontaneous hyphema, especially when emanating from pupillary border.

1.
Bennett
TJ
,
Barry
CJ
.
Ophthalmic imaging today: an ophthalmic photographer’s viewpoint: a review
.
Clin Exp Ophthalmol
.
2009
;
37
(
1
):
2
13
.
2.
Ozdalga
E
,
Ozdalga
A
,
Ahuja
N
.
The smartphone in medicine: a review of current and potential use among physicians and students
.
J Med Internet Res
.
2012
;
14
(
5
):
e128
.
3.
Chuchu
N
,
Takwoingi
Y
,
Dinnes
J
,
Matin
RN
,
Bassett
O
,
Moreau
JF
, et al.
,
Smartphone applications for triaging adults with skin lesions that are suspicious for melanoma
.
Cochrane Database Syst Rev
.
2018
;
12
:
CD013192
.
4.
Guterman
EL
,
Botelho
JV
,
Horton
JC
.
Diagnosis of tensilon-negative ocular myasthenia gravis by daily selfie
.
J Neuroophthalmol
.
2016
;
36
(
3
):
292
3
.
5.
Hogarty
DT
,
Hogarty
JP
,
Hewitt
AW
.
Smartphone use in ophthalmology: what is their place in clinical practice?
Surv Ophthalmol
.
2020
;
65
(
2
):
250
62
.
6.
Gupta
SC
,
Sinha
SK
,
Dagar
AB
.
Evaluation of the effectiveness of diagnostic & management decision by teleophthalmology using indigenous equipment in comparison with in-clinic assessment of patients
.
Indian J Med Res
.
2013
;
138
(
4
):
531
5
.
7.
HU
WF
,
Lorch
AC
.
Teleophthalmology for anterior segment disease
.
Int Ophthalmol Clin
.
2019
;
59
(
4
):
55
67
.
8.
Shields
JA
,
Bianciotto
C
,
Kligman
BE
,
Shields
CL
.
Vascular tumors of the iris in 45 patients: the 2009 Helen Keller Lecture
.
Arch Ophthalmol
.
2010
;
128
(
9
):
1107
13
.
9.
Shields
CL
,
Kancherla
S
,
Patel
J
,
Vijayvargiya
P
,
Suriano
MM
,
Kolbus
E
, et al.
Clinical survey of 3680 iris tumors based on patient age at presentation
.
Ophthalmology
.
2012
;
119
(
2
):
407
14
.
10.
Williams
BK
 Jr
,
Di Nicola
M
,
Ferenczy
S
,
Shields
JA
,
Shields
CL
.
Iris microhemangiomatosis: clinical, fluorescein angiography, and optical coherence tomography angiography features in 14 consecutive patients
.
Am J Ophthalmol
.
2018
;
196
:
18
25
.
11.
Goyal
S
,
Foster
PJ
,
Siriwardena
D
.
Iris vascular tuft causing recurrent hyphema and raised IOP: a new indication for laser photocoagulation, angiographic follow-up, and review of laser outcomes
.
J Glaucoma
.
2010
;
19
(
5
):
336
8
.
12.
Winnick
M
,
Margalit
E
,
Schachat
AP
,
Stark
WJ
.
Treatment of vascular tufts at the pupillary margin before cataract surgery
.
Br J Ophthalmol
.
2003
;
87
(
7
):
920
1
.
13.
Strauss
EC
,
Aldave
AJ
,
Spencer
WH
,
Branco
BC
,
Barsness
DA
,
Calman
AF
, et al.
Management of prominent iris vascular tufts causing recurrent spontaneous hyphema
.
Cornea
.
2005
;
24
(
2
):
224
6
.
14.
Kaya
A
.
Ophthoselfie: detailed self-imaging of cornea and anterior segment by smartphone
.
Turk J Ophthalmol
.
2017
;
47
(
3
):
130
2
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.